Elekta AB (publ)
Elekta AB (publ) (EKTAY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EKTAY · as of Jun 8, 2026
Key Statistics
Explore Elekta AB (publ) Data
ektay stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
ektay competitorsEKTAY
ARSUF
BOEUF
EBOSY
GENSF
GRRMFStock Performance
Full HistoryAbout Elekta AB (publ)
Elekta AB (publ) a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a…
what is elekta ab (publ) · ektay stock overview · elekta ab (publ) company profile · who is elekta ab (publ) ceo · ektay OTC · elekta ab (publ) headquarters · elekta ab (publ) business segments
About Stock Overview & Key Data
Elekta AB (publ) (EKTAY) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on OTC since Mar 3, 2009. As of the latest trading session, EKTAY stock price is $5.71, with a market capitalization of $2.2B. The stock has returned +8.56% over the past 12 months and -6.72% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Elekta AB (publ) stock is Hold, with an average 12-month price target of $—. In fiscal year 2026, Elekta AB (publ) reported revenue of $16.4B and net income of -$509.7M. For detailed data — including Elekta AB (publ) revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Elekta AB (publ) (EKTAY) stock price is $5.71. The stock is traded on OTC under the ticker symbol EKTAY. The 52-week range is $4.35 – $6.93.